TY - JOUR
T1 - Prostaglandin F2α metabolite levels in plasma, amniotic fluid, and urine during pregnancy and labor
AU - Satoh, Kazuo
AU - Yasumizu, Takehiko
AU - Fukuoka, Hideoki
AU - Kinoshita, Katsuyuki
AU - Kaneko, Yoshiharu
AU - Tsuchiya, Mitose
AU - Sakamoto, Shoichi
PY - 1979/4/15
Y1 - 1979/4/15
N2 - Levels of 13, 14-dihydro 15-keto-prostaglandin F2α (dhk PGF2α) in the plasma of 30 patients as well as in the amniotic fluid of 17 patients, and 5α, 7α-dihydroxy 11-keto tetranor-prostane 1,16-dioic acid (the main urinary metabolite of PGF2α [PGF2α MUM]) levels in the urine of 30 patients were measured by radioimmunoassay during pregnancy, labor, and the puerperium. During pregnancy, no increase in dhk PGF2α (ng/ml) in plasma was detected as the time of delivery approached. The levels of dhk PGF2α during the second stage (0.64 ± 0.15) and also at delivery (0.88 ± 0.27) were significantly elevated over those in the first stage (0.38 ± 0.29) (P <0.025 and P < 0.005, respectively). Its level 2 hours after delivery was reduced to predelivery levels. Its levels in umbilical arterial and venous blood were 0.71 ± 0.26 and 0.67 ± 0.26, respectively. A significant elevation (P < 0.01) of dhk PGF2α from 0.89 ± 0.21 before labor to 6.16 ± 2.40 at delivery was found in amniotic fluid. The hourly excretion of PGF2α MUM (μg/hour) increased significantly from pregnancy levels to 1.06 ± 0.45 in the first stage (P < 0.01), to 7.67 ± 4.31 (P < 0.005) for the first 2 hours after delivery, and 2.37 ± 1.08 from 2 to 12 hours after delivery (P < 0.01). The excretion of PGF2α MUM decreased to pregnancy levels 12 hours post partum. These data indicate that during labor the production of PGF2α is remarkably increased.
AB - Levels of 13, 14-dihydro 15-keto-prostaglandin F2α (dhk PGF2α) in the plasma of 30 patients as well as in the amniotic fluid of 17 patients, and 5α, 7α-dihydroxy 11-keto tetranor-prostane 1,16-dioic acid (the main urinary metabolite of PGF2α [PGF2α MUM]) levels in the urine of 30 patients were measured by radioimmunoassay during pregnancy, labor, and the puerperium. During pregnancy, no increase in dhk PGF2α (ng/ml) in plasma was detected as the time of delivery approached. The levels of dhk PGF2α during the second stage (0.64 ± 0.15) and also at delivery (0.88 ± 0.27) were significantly elevated over those in the first stage (0.38 ± 0.29) (P <0.025 and P < 0.005, respectively). Its level 2 hours after delivery was reduced to predelivery levels. Its levels in umbilical arterial and venous blood were 0.71 ± 0.26 and 0.67 ± 0.26, respectively. A significant elevation (P < 0.01) of dhk PGF2α from 0.89 ± 0.21 before labor to 6.16 ± 2.40 at delivery was found in amniotic fluid. The hourly excretion of PGF2α MUM (μg/hour) increased significantly from pregnancy levels to 1.06 ± 0.45 in the first stage (P < 0.01), to 7.67 ± 4.31 (P < 0.005) for the first 2 hours after delivery, and 2.37 ± 1.08 from 2 to 12 hours after delivery (P < 0.01). The excretion of PGF2α MUM decreased to pregnancy levels 12 hours post partum. These data indicate that during labor the production of PGF2α is remarkably increased.
UR - http://www.scopus.com/inward/record.url?scp=0018340259&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0018340259&partnerID=8YFLogxK
M3 - Article
C2 - 434032
AN - SCOPUS:0018340259
SN - 0002-9378
VL - 133
SP - 886
EP - 890
JO - American Journal of Obstetrics and Gynecology
JF - American Journal of Obstetrics and Gynecology
IS - 8
ER -